FindTrial
Sign In

Prevalence of Weight-Related Health Problems in Different Weight Groups Across India, Pakistan, Philippines, and Vietnam

Prevalence of weight related complications across Diverse Weight Classifications A large cross-sectional study in India, Pakistan, Philippines and Vietnam - WEIGHT DIVERSE Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/01/079165
Enrollment
1165
Registered
2025-01-21
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E669- Obesity, unspecified Health Condition 2: E668- Other obesity Health Condition 3: E663- Overweight

Interventions

None listed

Sponsors

Novo Nordisk India Private Limited
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Informed consent obtained before any study-related activities (study-related activities are any procedure related to recording of data according to the protocol). 2. Male or female aged 18 years or older at the time of signing informed consent. 3. Presence of atleast one Weight-related complication. complications.

Exclusion criteria

Exclusion criteria: 1. Participants aged less than 18 years at the time of signing informed consent. 2. Pregnant women and individuals with recent weight loss due to illness, defined as more than 5% weight loss in the past 6 months.

Design outcomes

Primary

MeasureTime frame
Proportion of weight-related complications across different BMI classesTimepoint: Baseline—

Secondary

MeasureTime frame
Proportion of weight-related complications across different anthropometric measurements and body indices, such as waist circumference, waist-height ratio, waist-hip ratio, and parameters of body composition analysis (Bioimpedance analysis [Optional])Timepoint: Baseline—

Countries

India, Pakistan, Philippines, Viet Nam

Contacts

Public ContactDr Aparna Manjunath

Novo Nordisk India Private Limited

apmh@novonordisk.com9148263232

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026